logo

CAMP

CAMP4 Therapeutics·NASDAQ
--
--(--)
--
--(--)
4.10 / 10
Netural

The equity's fundamental score is 4.1/10. Key strengths are its Revenue-MV (-2.77, group 1) and Profit-MV (0.46, group 1) factors, indicating room for growth relative to market value. However, Current assets turnover (0.04, group 1) and Fixed assets turnover (0.93, group 1) are subpar, limiting efficiency. Gross profit margin is a standout at 100% (group 4), but the PB-ROE (-0.35, group 3) is negative, suggesting valuation concerns. Net profit / total profit is also 100% (group 1), yet the low asset-turnover ratios temper the overall picture. This blend of factors results in an average fundamental stance that is neither clearly bullish nor bearish.

Fundamental(4.1)SentimentTechnical

Analysis Checks(6/10)

Revenue-MV
Value-2.77
Score2/3
Weight19.49%
1M Return11.69%
Inventory turnover ratio
Value47.85
Score3/3
Weight7.50%
1M Return5.26%
Gross profit margin (%)
Value100.00
Score3/3
Weight17.16%
1M Return10.80%
Profit-MV
Value0.46
Score2/3
Weight12.79%
1M Return7.79%
PB-ROE
Value-0.35
Score0/3
Weight5.84%
1M Return3.56%
Current assets turnover ratio
Value0.04
Score0/3
Weight-2.34%
1M Return-1.88%
Fixed assets turnover ratio
Value0.93
Score1/3
Weight-2.03%
1M Return-1.64%
Asset-MV
Value-0.50
Score2/3
Weight29.17%
1M Return15.13%
Cash-MV
Value-0.07
Score2/3
Weight12.80%
1M Return7.73%
Net profit / Total profit (%)
Value100.00
Score0/3
Weight-0.38%
1M Return-0.30%
Is CAMP fundamentally strong?
  • CAMP scores 4.10/10 on fundamentals and holds a Fair valuation at present. Backed by its -65.87% ROE, -1404.47% net margin, -3.73 P/E ratio, 3.40 P/B ratio, and 159.69% earnings growth, these metrics solidify its Netural investment rating.